By Bhanvi Satija and Prerna Bedi July 10 (Reuters) - GSK said on Friday that partner Hansoh Pharmaceutical's experimental ...
June 9 (Reuters) - British drugmaker GSK on Tuesday agreed to acquire U.S.-listed cancer drug developer Nuvalent for $10.6 billion to boost its lung cancer portfolio. The all-cash deal values Nuvalent ...
Britain's GSK has announced its $10.6 billion acquisition of US-based cancer-focused biopharma firm Nuvalent, paying a 40% ...
Zacks Investment Research on MSN
GSK's Jemperli delivers promising interim data in rectal cancer
GSK plc GSK has announced positive interim data from a mid-stage study evaluating its oncology drug, Jemperli (dostarlimab), ...
GSK on Tuesday upped its 2024 profit guidance, as surging sales of its HIV drugs and recently launched shingles vaccine saw it beat analyst expectations in the first quarter of the year. The FTSE-100 ...
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial, keeping the drugmaker in the race to bring the technology to ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics RAPT for an estimated aggregate equity value of $2.2 billion. The impending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results